MITOXANTRONE IN THE TREATMENT OF ADVANCED VULVAR AND VAGINAL-CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：28
|
作者：
MUSS, HB
BUNDY, BN
CHRISTOPHERSON, WA
机构：
[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT MED,WINSTON SALEM,NC 27103
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[3] UNIV PITTSBURGH,MAGEE WOMENS HOSP,DEPT OBSTET & GYNECOL,PITTSBURGH,PA 15213
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1989年 / 12卷 / 02期
关键词：
D O I：
10.1097/00000421-198904000-00011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：142 / 144
页数：3
相关论文
共 50 条
  • [41] PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE VULVA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    LEWIS, GC
    GYNECOLOGIC ONCOLOGY, 1986, 23 (03) : 358 - 363
  • [42] PHASE-II STUDY OF VINBLASTINE IN PREVIOUSLY TREATED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SUTTON, GP
    BLESSING, JA
    BARNES, W
    BALL, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (06): : 470 - 471
  • [43] A PHASE-II CLINICAL-TRIAL OF DIAZIQUONE IN THE TREATMENT OF PATIENTS WITH RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    DISAIA, PJ
    PHILLIPS, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (06): : 612 - 613
  • [44] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE VULVA AND CARCINOMA OF THE VAGINA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    BEECHAM, J
    DISAIA, PJ
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 869 - 870
  • [45] A PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF STAGE 1 SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    DELGADO, G
    BUNDY, BN
    FOWLER, WC
    STEHMAN, FB
    SEVIN, B
    CREASMAN, WT
    MAJOR, F
    DISAIA, P
    ZAINO, R
    GYNECOLOGIC ONCOLOGY, 1989, 35 (03) : 314 - 320
  • [46] MITOXANTRONE (NSC-301739) IN PATIENTS WITH ADVANCED CERVICAL-CARCINOMA - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    MUSS, HB
    SUTTON, GP
    BUNDY, B
    HATCH, KD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (04): : 312 - 315
  • [47] MITOXANTRONE (NSC-301739) IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    MUSS, HB
    ASBURY, R
    BUNDY, B
    EHRLICH, CE
    GRAHAM, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (06): : 737 - 739
  • [48] SOUTHWEST-ONCOLOGY-GROUP STUDY OF MITOXANTRONE FOR TREATMENT OF PATIENTS WITH ADVANCED ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK
    MATTOX, DE
    VONHOFF, DD
    BALCERZAK, SP
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (01) : 105 - 107
  • [49] TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA WITH MEDROXYPROGESTERONE ACETATE (MPA) - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, T
    BLESSING, J
    DISAIA, P
    EHRLICH, C
    GYNECOLOGIC ONCOLOGY, 1985, 20 (02) : 250 - 250
  • [50] Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer
    Toshiaki Saito
    Tsutomu Tabata
    Hitoshi Ikushima
    Hiroyuki Yanai
    Hironori Tashiro
    Hitoshi Niikura
    Takeo Minaguchi
    Toshinari Muramatsu
    Tsukasa Baba
    Wataru Yamagami
    Kazuya Ariyoshi
    Kimio Ushijima
    Mikio Mikami
    Satoru Nagase
    Masanori Kaneuchi
    Nobuo Yaegashi
    Yasuhiro Udagawa
    Hidetaka Katabuchi
    International Journal of Clinical Oncology, 2018, 23 : 201 - 234
12345